Beleggen.nl
Uitgebreid zoeken
Markt MonitorMarkt Monitor

BioPharma Terug naar discussie overzicht

Pegasus Wireless - PGWC

1.162 Posts
Pagina: «« 1 ... 24 25 26 27 28 ... 59 »» | Laatste | Omlaag ↓
  1. [verwijderd] 10 oktober 2006 20:04

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Als PGWC nu eens dezelfde stijging als ADL laat zien:-)

    ADL 4.60
    Day's Low & High: 3.5101 - 4.95
    Open: 3.75
    Previous Close: 3.22
    Volume: 127,200
    Avg. Volume: 115,555
    Market Capitalization: 30.75 M
    52-week range: 0.25 to 3.30
    1 week change: 88.18%
    1 month change: 993.23%

    1000% in 1 maand ... wow!
  19. [verwijderd] 13 oktober 2006 08:41

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Pegasus Clips Its Own Wings
    By Seth Jayson (TMF Bent)
    September 26, 2006

    Hobbling your own horse
    It's no surprise to me that Pegasus Wireless (Nasdaq: PGWC) is delisting from the Nasdaq. The novelty is that it seems to have made the decision to do so on its own. Normally, getting tossed off the Naz onto the Amex, or the OTC Bulletin Board, would be a mark of shame, but Pegasus CEO Jasper Knabb claims that this move is "in the best interests" of the company or shareholders. Read a bit more of the press release and you'll see why.

    Knabb is, once again, trying to fight the shorts. He's dismayed at the volume of trading on his stock, the release says, and even worse, the price decline.

    Why Knabb, or anyone, for that matter, believes that moving the stock to a less liquid market can possibly help with volatility is beyond comprehension. I can't believe he could even make that argument with a straight face, but I'm sure it will play well with the message-board peanut gallery, which has been screaming about shorting (and alleged naked shorting) for weeks now.

    Me, I like to savor the hypocrisy: Neither Knabb nor his cheerleading shareholders seemed so concerned about the volume and price increases that occurred earlier in the year. Let's be clear here. The run-up was completely unwarranted. The move tripled the stock of this marginally profitable company -- an outfit that has sported negative free cash flow since 2004. At $18 a share back in May, Pegasus was worth nearly $1.5 billion, or about 18 times trailing revenues. In other words, this thing was horrendously overvalued.

    Wait, stocks can go down, too?
    But, hey, no one cares about crazy trading when the stock goes up. When things turn the other way, though, watch out. The first hint that Knabb was concerned about the share price was probably the warrant scheme, which was an attempt to pull borrowed shares back from shorts by promising shareholders a warrant only if they took their stock out of street name. The next was the abrupt halt of Knabb's previously well-publicized "insider buying" campaign.

    The warrant scheme was the catalyst that convinced me to dig a lot more deeply into the histories of Knabb and CFO Stephen Durland, and what I found was pretty ugly. Overhyped companies that rise and fall to near zilch. Penny stocks galore. Lawsuits. Paid promoters. Disbarred lawyers. Get the full story here.

    Short story, tall tale
    But in this day and age, even a CEO and CFO with an amazing record of microcap tomfoolery can find a sympathetic ear out there -- at least if they've got a market story with sufficient nudity.

    Enter Forbes' Liz Moyer, who seems to have swallowed the Pegasus peanut gallery's short story hook, line, and sinker. Worse yet, she believes the Pegasus corporate party line -- that an unproven outfit like Pegasus is going to outmaneuver Apple (Nasdaq: AAPL), Hewlett-Packard (NYSE: HPQ), Cisco (Nasdaq: CSCO), and everyone else playing in the hotly contested PC-to-TV video-streaming market. I'm not kidding. She opens her Monday night article with this line, "Jasper Knabb and his streaming video technology is [sic] about to beat Steve Jobs to the punch."

    Beat Steve Jobs to the punch? Trust me, they're not quaking in Cupertino. Nor is anyone else. That's because Pegasus isn't beating anyone to the punch on this. PC-to-TV streaming products already exist. Among current providers is a little company called Microsoft (Nasdaq: MSFT), which already sells two separate systems that can stream video from a PC to a TV, one of them being the very popular Xbox 360.

    Down the rabbit hole
    Pegasus is already 50 shades of weird, but it gets crazier all the time. Recently, I've noticed that one of the biggest message-board knuckleheads out there, a guy who pumps Pegasus relentlessly at Yahoo! Finance, seems remarkably well informed about Pegasus' upcoming press. I mean, he sometimes seems to know what's going to happen before it happens. I normally don't pay too much attention to the rantings of folks like this, but recently I've had to wonder. How does a guy who can't find and deactivate his caps lock key know this stuff?

    In the past, he's told me about Pegasus PR hours before it hit the wires. And over the past few days, he's been promising a sympathetic article from a well-known business magazine. Was he talking about the Moyers piece for Forbes?

    Is management feeding him this info, or is this all just a lucky coincidence?

    Hey, maybe it's nothing, but it sure looks strange, and it doesn't do anything to instill my confidence in Pegasus' management.

    Foolish bottom line
    As I've noted before, battling the shorts via warrant grants or other manipulative means is not likely to be a successful approach. (The research is here.) Shareholders take note: According to that research paper, investing in companies that battle shorts is a good way to generate returns of -2% per month.

    In fact, I'm convinced that Knabb brought most of the recent downward pressure on himself. His short-sighted crusade against the shorts certainly made headlines, but of the wrong kind, alas. Smart shorts out there know that CEOs with something to bring to the table -- for instance, sustainable growth and earnings -- would just shut up and bury the shorts with results.

    Trying to fight shorts by releasing short-busting PR is like trying to restore your severed finger by dipping your bleeding hand in a shark tank.

    Adding it all up, things look pretty bad for anyone with faith in Pegasus. The stock has dropped as much as 28% already today. And if the price history of other companies fronted by Knabb and Durland is any indication, I wouldn't be surprised to see Pegasus trading for even fewer pennies very soon.

    Don't be suckered in by Knabb's exchange-swaps or Forbes' reassurances, Fools. Moyer is just plain wrong on this one. There are plenty of good reasons for Pegasus' huge fall, and unless Knabb can deliver something other than gimmicks and PR, Pegasus will be no phoenix.

    www.fool.com/news/commentary/2006/com...
  20. [verwijderd] 13 oktober 2006 08:52

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Wall Street group sues Utah over short-sales rule
    Fri Jul 28, 2006 6:23 PM ET

    By Kevin Drawbaugh

    WASHINGTON, July 28 (Reuters) - The Securities Industry Association (SIA), which represents Wall Street interests, said on Friday it filed a lawsuit in federal court seeking to block a Utah law aimed at curbing naked short selling, a controversial investment strategy.

    The association said the Utah legislation illegally usurps the jurisdiction of the Securities and Exchange Commission and is expressly preempted by federal securities law.

    "On this issue, federal law could not be more explicit: the states are expressly prohibited from establishing ... requirements that are different from the requirements of the Securities Exchange Act," said SIA President Marc Lackritz.

    At issue is a law adopted by Utah in May targeting an investment practice that has been attacked repeatedly over the years by Patrick Byrne, chief executive of Overstock.com Inc. , an online retailer based in Salt Lake City.

    Short sellers borrow shares they view as overvalued from a brokerage, then sell them and wait for the market price to decline. If it does, then the short seller buys the shares back, returns them to the brokerage and pockets a profit on the difference between the sale and the repurchase prices.

    Short selling is legal and common, especially among hedge funds, the lightly regulated and fast-growing capital pools that are playing an increasingly powerful role on Wall Street.

    Naked short sellers take short positions in a stock without ever arranging to borrow the shares to cover their initial sales.

    Earlier this month, the SEC voted 5-0 to propose a crackdown on naked shorting that would reduce the number of short positions that can be open without borrowed shares being delivered and narrow a related exception for market makers.

    Utah acted alone on this issue two months ago when it adopted a law requiring brokerages to inform state regulators when sold shares are not delivered to the purchaser. Such "failures to deliver" sometimes signal naked shorting.

    Brokerages that do not comply with the reporting law must pay $10,000 a day to Utah-domiciled companies whose shares are involved. The law is scheduled to take effect on Oct. 1.

    The SIA filed its lawsuit in U.S. District Court for the District of Utah, Central Division. The group contends that the Utah law is too broad and covers transactions unrelated to shorting. Wall Street firms have said before that failures to deliver after a sale sometimes have nothing to do with shorts.

    The SIA said, "In some cases the systems required to locate and report the information are simply unavailable."

    Asked whether the SEC might file a brief with the court, commission spokesman John Nester said, "Staff is reviewing whether to recommend filing a friend of the court brief, but no decisions have been made."

    A spokeswoman for the Utah Division of Securities declined to comment.

1.162 Posts
Pagina: «« 1 ... 24 25 26 27 28 ... 59 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.003
AB InBev 2 5.486
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.273
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.555
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.657
Aedifica 3 902
Aegon 3.258 322.677
AFC Ajax 538 7.087
Affimed NV 2 6.288
ageas 5.844 109.887
Agfa-Gevaert 14 2.048
Ahold 3.538 74.302
Air France - KLM 1.025 35.008
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.370
Allfunds Group 4 1.469
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.819
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.822
AMG 971 133.147
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.960
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.733
Arcelor Mittal 2.033 320.620
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.724
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.087
ASML 1.766 106.207
ASR Nederland 21 4.452
ATAI Life Sciences 1 7
Atenor Group 1 484
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.639
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392